Late effects of cancer treatment in breast cancer survivors
- PMID: 24818106
- PMCID: PMC4014641
- DOI: 10.4103/2278-330X.130445
Late effects of cancer treatment in breast cancer survivors
Abstract
Postoperative radiation therapy (RT) and chemotherapy,both reduces the risk of local recurrence and extends overall survival in patients with breast cancer (BC). Concerns have, however, been raised about the risk of acute and chronic side effects in breast cancer survivors as the number of treated individuals is large and their expected survival is long compared to most patients with other malignant diseases. Cardiac toxicity, reproductive dysfunction, pneumonitis (RP),arm lymph edema, neuropathy, skin changes are examples of the wide range of complications that has been associated with adjuvant treatment.
Keywords: Breast cancer survivors; cancer treatment; late effects.
Conflict of interest statement
Similar articles
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?Breast J. 2005 Sep-Oct;11(5):317-20. doi: 10.1111/j.1075-122X.2005.21696.x. Breast J. 2005. PMID: 16174151
-
Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):386-91. doi: 10.1016/j.ijrobp.2004.09.044. Int J Radiat Oncol Biol Phys. 2005. PMID: 15890579
-
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):144-55. doi: 10.1016/s0360-3016(01)01759-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 11777632
-
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.J Clin Oncol. 2007 Sep 1;25(25):3991-4008. doi: 10.1200/JCO.2007.10.9777. Epub 2007 Jun 18. J Clin Oncol. 2007. PMID: 17577017 Review.
Cited by
-
Adverse health effects after breast cancer up to 14 years after diagnosis.Breast. 2022 Feb;61:22-28. doi: 10.1016/j.breast.2021.12.001. Epub 2021 Dec 3. Breast. 2022. PMID: 34891036 Free PMC article. Review.
-
Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control.Antioxidants (Basel). 2019 Apr 16;8(4):103. doi: 10.3390/antiox8040103. Antioxidants (Basel). 2019. PMID: 30995775 Free PMC article. Review.
-
Fertility preservation in young patients with cancer.South Asian J Cancer. 2015 Jul-Sep;4(3):134-9. doi: 10.4103/2278-330X.173175. South Asian J Cancer. 2015. PMID: 26942145 Free PMC article. Review.
-
Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors.J Cancer Surviv. 2024 Aug;18(4):1243-1251. doi: 10.1007/s11764-023-01365-6. Epub 2023 Mar 24. J Cancer Surviv. 2024. PMID: 36964293 Free PMC article.
-
Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects.Front Immunol. 2017 May 2;8:506. doi: 10.3389/fimmu.2017.00506. eCollection 2017. Front Immunol. 2017. PMID: 28512460 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention (CDC). Cancer survivorship-United States, 1971-2001. MMWR Morb Mortal Wkly Rep. 2004;53:526–9. - PubMed
-
- Dinshaw KA, Budrukkar AN, Chinoy RF, Sarin R, Badwe R, Hawaldar R, et al. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2005;63:1132–41. - PubMed
-
- Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808–15. - PubMed
-
- Ewer MS, Vooletich MT, Durand JB, Woods ML, Davis JR, Valero V, et al. Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment. J Clin Oncol. 2005;23:7820–6. - PubMed
-
- Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol. 1998;16:2625–31. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources